STOCK-BASED COMPENSATION PLANS - Summary of Stock Option Activity (Details) - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Options
Outstanding, beginning of period (in shares)	531,915	552,669	588,024
Granted (in shares)		126,794	136,506
Exercised (in shares)	(116,590)	(113,728)	(86,145)
Canceled (in shares)	(15,387)	(33,820)	(85,716)
Outstanding, end of period (in shares)	399,938	531,915	552,669	588,024
Exercisable, end of period (in shares)	293,952
Weighted Average Exercise Price
Outstanding, beginning of period (in dollars per share)	$ 75.40	$ 69.82	$ 63.36
Granted (in dollars per share)		81.21	77.75
Exercised (in dollars per share)	68.57	50.38	35.47
Canceled (in dollars per share)	77.10	73.53	73.73
Outstanding, end of period (in dollars per share)	77.32	$ 75.40	$ 69.82	$ 63.36
Exercisable, end of period (in dollars per share)	$ 76.45
Weighted Average Remaining Contractual Life
Outstanding (in years)	5 years 10 months 24 days	6 years 6 months	6 years 1 month 6 days	5 years 8 months 12 days
Exercisable, end of period (in years)	5 years 9 months 18 days
Aggregate Intrinsic Value
Outstanding, beginning of period	$ 9	$ 4	$ 9
Granted		0	0
Exercised	0	0	0
Canceled	0	0	0
Outstanding, end of period	11	$ 9	$ 4	$ 9
Exercisable, end of period	$ 7

The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.